{"id":"https://openalex.org/W2371726552","doi":null,"title":"EFFECTS OF DYNORPHINE AND PHENCYCLIDINE ON THE CYCLIC ADENOSINE MONOPHOS PHATE GENERATING SYSTEM IN THE SPONTANEOUSLY HYPERTENSIVE RATS PERIPHERAL ARTERIES","display_name":"EFFECTS OF DYNORPHINE AND PHENCYCLIDINE ON THE CYCLIC ADENOSINE MONOPHOS PHATE GENERATING SYSTEM IN THE SPONTANEOUSLY HYPERTENSIVE RATS PERIPHERAL ARTERIES","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W2371726552","mag":"2371726552"},"language":"en","primary_location":{"id":"mag:2371726552","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZSJK199501003.htm","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047388991","display_name":"Wei Bao","orcid":"https://orcid.org/0000-0002-7301-5786","observed_orcids":["https://orcid.org/0000-0002-7301-5786"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wei Bao","raw_affiliation_strings":["ZHANG An - Zhong"],"raw_orcid":"https://orcid.org/0000-0002-7301-5786","affiliations":[{"raw_affiliation_string":"ZHANG An - Zhong","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5047388991"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16479919,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9077000021934509,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9077000021934509,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.050599999725818634,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.029100000858306885,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/camp","display_name":"cyclic AMP","score":0.9169999957084656},{"id":"https://openalex.org/keywords/adenylate-cyclase","display_name":"adenylate cyclase","score":0.9679999947547913},{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.8560000061988831},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8880000114440918},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.9660000205039978},{"id":"https://openalex.org/keywords/peripheral-arteries","display_name":"peripheral arteries","score":0.9440000057220459},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7609999775886536},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.5479999780654907},{"id":"https://openalex.org/keywords/receptor-sensitivity","display_name":"receptor sensitivity","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8086479902267456},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7879915833473206},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6449631452560425},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.5877861976623535},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.5195739269256592},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.5079613327980042},{"id":"https://openalex.org/C2780069284","wikidata":"https://www.wikidata.org/wiki/Q5198121","display_name":"Cyclase","level":3,"score":0.4996621608734131},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.477949857711792},{"id":"https://openalex.org/C2776668983","wikidata":"https://www.wikidata.org/wiki/Q210041","display_name":"Cyclic adenosine monophosphate","level":3,"score":0.43691179156303406},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42544788122177124},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.385515421628952},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2371726552","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZSJK199501003.htm","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2470855448","https://openalex.org/W2078560486","https://openalex.org/W2023113357","https://openalex.org/W4245114869","https://openalex.org/W2347853717","https://openalex.org/W2011321249","https://openalex.org/W2402842207","https://openalex.org/W2397077386","https://openalex.org/W2074212602","https://openalex.org/W2065149264"],"abstract_inverted_index":{"The":[0,87,105],"effect":[1,56,89],"of":[2,23,57,90,123,131,142],"the":[3,9,24,54,63,69,96,102,124,129],"kappa-receptor":[4],"agonist":[5,13],"dynorphine":[6],"(Dyn)":[7],"and":[8,45,83,111,116,136],"phencyclidine":[10],"(PCP)":[11],"-receptor":[12],"PCP":[14,72,91,112,137],"on":[15],"3'":[16],"-5'":[17],"-cyclic":[18],"adenosine":[19],"monophosphate":[20],"(cAMP)generating":[21],"system":[22],"spontaneously":[25],"hypertensive":[26],"rat":[27,49],"(SHR)":[28],"arteries":[29,65,98,118,133],"was":[30,59,92,138],"studied":[31],"in":[32,38,42,62,68,76,80,95,101],"vitro.":[33],"Dyn":[34,58,110,135],"decreased":[35],"cAMP":[36,74,126],"levels":[37,75],"a":[39,77],"dose-dependent":[40,78],"manner":[41,79],"both":[43,81],"SHR":[44,64,82,103,115,132],"normotensive":[46],"Wistar":[47],"Kyoto":[48],"(WKy)":[50],"peripheral":[51,85],"arteries,":[52],"but":[53],"inhibitory":[55],"statistically":[60,93],"greater":[61,94],"than":[66,99],"that":[67,100,108,141],"WKy":[70,84,97,117,143],"ones.":[71,104],"increased":[73],"arteries.":[86,144],"stimulatory":[88],"findings":[106],"indicate":[107],"(1)":[109],"can":[113],"affect":[114],"through":[119],"inhibition":[120],"or":[121],"activation":[122],"adenylate-cyclase":[125],"system,":[127],"(2)":[128],"sensitivity":[130],"to":[134],"different":[139],"from":[140]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}